Brokers Set Expectations for MKS’s Q4 Earnings (NASDAQ:MKSI)

MKS Inc. (NASDAQ:MKSI) – Zacks Research boosted their Q4 2026 earnings per share estimates for shares of MKS in a report released on Wednesday, August 26th. Zacks Research analyst Team now anticipates that the scientific and technical instruments company will earn $3.56 per share for the quarter, up from their previous estimate of $3.42. The consensus estimate for MKS’s current full-year earnings is $12.96 per share. Zacks Research also issued estimates for MKS’s Q1 2027 earnings at $3.73 EPS, Q2 2027 earnings at $4.09 EPS, Q4 2027 earnings at $4.06 EPS, Q1 2028 earnings at $5.09 EPS and Q2 2028 earnings at $4.83 EPS.

MKS (NASDAQ:MKSI) last issued its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.39. The business had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.20 billion. MKS had a net margin of 10.15% and a return on equity of 24.72%. The business’s revenue was up 28.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.77 earnings per share. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS.

Several other research analysts have also commented on the company. Deutsche Bank Aktiengesellschaft set a $360.00 target price on MKS in a research report on Friday, July 31st. Mizuho reduced their price objective on MKS from $360.00 to $330.00 and set an “outperform” rating on the stock in a research note on Tuesday. Morgan Stanley boosted their target price on shares of MKS from $374.00 to $442.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Wall Street Zen upgraded shares of MKS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Finally, Wells Fargo & Company lifted their price target on shares of MKS from $300.00 to $325.00 and gave the company an “equal weight” rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $382.86.

MKS Trading Up 0.5%

Shares of NASDAQ MKSI opened at $271.75 on Thursday. The company has a quick ratio of 0.72, a current ratio of 1.14 and a debt-to-equity ratio of 0.85. The stock’s 50 day moving average price is $335.92 and its two-hundred day moving average price is $295.63. MKS has a 52-week low of $97.50 and a 52-week high of $447.62. The stock has a market capitalization of $18.38 billion, a P/E ratio of 43.34, a PEG ratio of 0.58 and a beta of 1.98.

MKS Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Tuesday, August 25th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Tuesday, August 25th. This represents a $1.00 annualized dividend and a yield of 0.4%. MKS’s dividend payout ratio is presently 15.95%.

Insider Buying and Selling

In related news, CAO Michelle M. Mccarthy sold 2,434 shares of the stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $315.23, for a total value of $767,269.82. Following the completion of the transaction, the chief accounting officer owned 2 shares in the company, valued at $630.46. This represents a 99.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Tseng-Chung Lee sold 10,000 shares of the firm’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $302.01, for a total transaction of $3,020,100.00. Following the transaction, the chief executive officer directly owned 134,776 shares in the company, valued at approximately $40,703,699.76. The trade was a 6.91% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,891 shares of company stock valued at $3,919,127 over the last 90 days. 0.57% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On MKS

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MKSI. Dorsey Wright & Associates acquired a new position in MKS in the first quarter worth approximately $1,329,000. Fifth Third Bancorp boosted its stake in shares of MKS by 3,011.9% during the 1st quarter. Fifth Third Bancorp now owns 19,294 shares of the scientific and technical instruments company’s stock worth $4,434,000 after acquiring an additional 18,674 shares in the last quarter. California Public Employees Retirement System boosted its stake in shares of MKS by 7.8% during the 1st quarter. California Public Employees Retirement System now owns 123,288 shares of the scientific and technical instruments company’s stock worth $28,333,000 after acquiring an additional 8,904 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of MKS in the 1st quarter worth $23,809,000. Finally, Anson Funds Management LP acquired a new stake in shares of MKS during the first quarter worth $3,792,000. Institutional investors own 99.79% of the company’s stock.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.